The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Inhibition of Acetyl-CoA Carboxylase by Phosphorylation or the Inhibitor ND-654 Suppresses Lipogenesis and Hepatocellular Carcinoma
Open accessAbstract
Summary The incidence of hepatocellular carcinoma (HCC) is rapidly increasing due to the prevalence of obesity and non-alcoholic fatty liver disease, but the molecular triggers that initiate disease development are not fully understood. We demonstrate that mice with targeted loss of function point mutations within the AMP-activated protein kinase (AMPK) phosphorylation sites acetyl-CoA carboxylase 1 (ACC1 Ser79Ala) and ACC2 (ACC2 Ser212Ala) have increased liver de novo lipogenesis (DNL) and liver lesions. The same mutation in ACC1 also increases DNL and proliferation human liver cancer cells. Consistent with these findings, a novel, liver specific ACC inhibitor (ND-654), that mimics the effects of ACC phosphorylation, inhibits hepatic DNL and the development of HCC, improving survival of tumor-bearing rats when used alone and in combination with the multi-kinase inhibitor sorafenib. These studies highlight the importance of DNL and dysregulation of AMPK-mediated ACC phosphorylation in accelerating HCC and the potential of ACC inhibitors for treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Global cancer statistics, 2012
Torre, L. A., Bray, F., Siegel, R. L., Ferlay, J., Lortet‐Tieulent, J., & Jemal, A. (2015) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21262 · Cited by 26,850
Sorafenib in advanced hepatocellular carcinoma
Llovet, J. M., Ricci, S., Mazzaferro, V., Hilgard, P., Gane, E., Blanc, J.-F., de Oliveira, A. C., Santoro, A., Raoul, J.-L., Forner, A., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0708857 · Cited by 13,097
A New Era of Systemic Therapy for Hepatocellular Carcinoma with Regorafenib and Lenvatinib
Kudo, M. (2017) · Liver Cancer · doi:10.1159/000462153 · Cited by 5,936
Sorafenib in Advanced Hepatocellular Carcinoma
정, 재. (2008) · Cited by 5,586
Donnelly, K. L., Smith, C. I., Schwarzenberg, S. J., Jessurun, J., Boldt, M. D., & Parks, E. J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23621 · Cited by 3,604
Phosphorylation of ULK1 (hATG1) by AMP-Activated Protein Kinase Connects Energy Sensing to Mitophagy
Egan, D. F., Shackelford, D. B., Mihaylova, M. M., Gelino, S., Kohnz, R. A., Mair, W., Vasquez, D. S., Joshi, A., Gwinn, D. M., Taylor, R., et al. (2011) · Science · doi:10.1126/science.1196371 · Cited by 2,600
Llovet, J. M., Zucman-Rossi, J., Pikarsky, E., Sangro, B., Schwartz, M., Sherman, M., & Gores, G. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.18 · Cited by 2,531
Park, E. J., Lee, J. H., Yu, G.-Y., He, G., Ali, S. R., Holzer, R. G., Österreicher, C. H., Takahashi, H., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2009.12.052 · Cited by 1,764
Hoshida, Y., Nijman, S. M. B., Kobayashi, M., Chan, J. A., Brunet, J.-P., Chiang, D. Y., Villanueva, A., Newell, P., Ikeda, K., Hashimoto, M., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1089 · Cited by 1,238
Self-citationFullerton, M. D., Galic, S., Marcinko, K., Sikkema, S., Pulinilkunnil, T., Chen, Z.-P., O'Neill, H. M., Ford, R. J., Palanivel, R., O'Brien, M., et al. (2013) · Nature Medicine · doi:10.1038/nm.3372 · Cited by 893
Self-citationAMPK, insulin resistance, and the metabolic syndrome
Ruderman, N. B., Carling, D., Prentki, M., & Cacicedo, J. M. (2013) · Journal of Clinical Investigation · doi:10.1172/jci67227 · Cited by 873
Hepatocellular carcinoma in non-alcoholic fatty liver disease: An emerging menace
Baffy, G., Brunt, E. M., & Caldwell, S. H. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.10.027 · Cited by 858
McGarry, J. D., Leatherman, G. F., & Foster, D. W. (1978) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)34693-8 · Cited by 600
Calvisi, D. F., Wang, C., Ho, C., Ladu, S., Lee, S. A., Mattu, S., Destefanis, G., Delogu, S., Zimmermann, A., Ericsson, J., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2010.12.006 · Cited by 595
Svensson, R. U., Parker, S. J., Eichner, L. J., Kolar, M. J., Wallace, M., Brun, S. N., Lombardo, P. S., Van Nostrand, J. L., Hutchins, A., Vera, L., et al. (2016) · Nature Medicine · doi:10.1038/nm.4181 · Cited by 536
Self-citationPalmitic acid induces production of proinflammatory cytokine interleukin-8 from hepatocytes
Joshi-Barve, S., Barve, S. S., Amancherla, K., Gobejishvili, L., Hill, D., Cave, M., Hote, P., & McClain, C. J. (2007) · Hepatology · doi:10.1002/hep.21752 · Cited by 406
Hoshida, Y. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015543 · Cited by 382
Self-citationFuchs, B. C., Hoshida, Y., Fujii, T., Wei, L., Yamada, S., Lauwers, G. Y., McGinn, C. M., DePeralta, D. K., Chen, X., Kuroda, T., et al. (2014) · Hepatology · doi:10.1002/hep.26898 · Cited by 351
Self-citationRegulation of Hepatic De Novo Lipogenesis in Humans
Hellerstein, M. K., Schwarz, J.-M., & Neese, R. A. (1996) · Annual Review of Nutrition · doi:10.1146/annurev.nu.16.070196.002515 · Cited by 349 · cited 18×
“Fructose-fed ACCKI mice also increased liver lipogenesis in vivo (Figure 1D), indicating that AMPK phosphorylation of ACC is vital to suppressing DNL.”
BackgroundInfluentialRahman, K., Desai, C., Iyer, S. S., Thorn, N. E., Kumar, P., Liu, Y., Smith, T., Neish, A. S., Li, H., Tan, S., et al. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.06.022 · Cited by 334
Fuchs, B. C., Fujii, T., Dorfman, J. D., Goodwin, J. M., Zhu, A. X., Lanuti, M., & Tanabe, K. K. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2460 · Cited by 309
Self-citationOpposing effects of fructokinase C and A isoforms on fructose-induced metabolic syndrome in mice
Ishimoto, T., Lanaspa, M. A., Le, M. T., Garcia, G. E., Diggle, C. P., MacLean, P. S., Jackman, M. R., Asipu, A., Roncal-Jimenez, C. A., Kosugi, T., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1119908109 · Cited by 298
Harriman, G., Greenwood, J., Bhat, S., Huang, X., Wang, R., Paul, D., Tong, L., Saha, A. K., Westlin, W. F., Kapeller, R., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1520686113 · Cited by 287
Self-citationCo-ordinate activation of lipogenic enzymes in hepatocellular carcinoma
Yahagi, N., Shimano, H., Hasegawa, K., Ohashi, K., Matsuzaka, T., Najima, Y., Sekiya, M., Tomita, S., Okazaki, H., Tamura, Y., et al. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2004.12.037 · Cited by 248
Nakagawa, S., Wei, L., Song, W. M., Higashi, T., Ghoshal, S., Kim, R. S., Bian, C. B., Yamada, S., Sun, X., Venkatesh, A., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.11.004 · Cited by 205
Self-citationRole of CYP2E1 in Diethylnitrosamine-Induced Hepatocarcinogenesis In vivo
Kang, J. S., Wanibuchi, H., Morimura, K., Gonzalez, F. J., & Fukushima, S. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1369 · Cited by 203
Fedirko, V., Lukanova, A., Bamia, C., Trichopolou, A., Trépo, E., Nöthlings, U., Schlesinger, S., Aleksandrova, K., Boffetta, P., Tjønneland, A. M., et al. (2012) · Annals of Oncology · doi:10.1093/annonc/mds434 · Cited by 135
Molecular classification of hepatocellular carcinoma: potential therapeutic implications
Goossens, N., Sun, X., & Hoshida, Y. (2015) · Hepatic Oncology · doi:10.2217/hep.15.26 · Cited by 135
Self-citationClinicopathological indices to predict hepatocellular carcinoma molecular classification
Tan, P. S., Nakagawa, S., Goossens, N., Venkatesh, A., Huang, T., Ward, S. C., Sun, X., Song, W., Koh, A. P., Canasto‐Chibuque, C., et al. (2015) · Liver International · doi:10.1111/liv.12889 · Cited by 101
Self-citationAcetyl-CoA carboxylase-a as a novel target for cancer therapy.
Wang, C., Rajput, S., Watabe, K., Liao, D.-F., & Cao, D. (2010) · Frontiers in Bioscience · doi:10.2741/s82 · Cited by 95
Myeloperoxidase and elastase are only expressed by neutrophils in normal and in inflammed liver
Amanzada, A., Malik, I. A., Nischwitz, M., Sultan, S., Naz, N., & Ramadori, G. P. (2011) · Histochemistry and Cell Biology · doi:10.1007/s00418-011-0787-1 · Cited by 95
DePeralta, D. K., Wei, L., Ghoshal, S., Schmidt, B. H., Lauwers, G. Y., Lanuti, M. D., Chung, R. T., Tanabe, K. K., & Fuchs, B. C. (2016) · Cancer · doi:10.1002/cncr.29912 · Cited by 81
Self-citationZhao, H., Desai, V., Wang, J., Epstein, D. M., Miglarese, M. R., & Buck, E. A. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0327 · Cited by 62
Finn, R. S., Aleshin, A. A., Dering, J., Yang, P. C., Ginther, C., Desai, A. J., Zhao, D., von Euw, E., Busuttil, R. W., & Slamon, D. J. (2013) · Hepatology · doi:10.1002/hep.26223 · Cited by 51
Schmidt, B. H., Wei, L., DePeralta, D. K., Hoshida, Y., Tan, P. S., Sun, X., Sventek, J. P., Lanuti, M. D., Tanabe, K. K., & Fuchs, B. C. (2015) · International Journal of Cancer · doi:10.1002/ijc.29893 · Cited by 38
Self-citationKumamoto, R., Uto, H., Oda, K., Ibusuki, R., Tanoue, S., Arima, S., Mawatari, S., Kumagai, K., Numata, M., Tamai, T., et al. (2013) · European journal of medical research · doi:10.1186/2047-783x-18-54 · Cited by 31
Cited by
Mechanisms and disease consequences of nonalcoholic fatty liver disease
Loomba, R., Friedman, S. L., & Shulman, G. I. (2021) · Cell · doi:10.1016/j.cell.2021.04.015 · Cited by 2,002
New insights into activation and function of the AMPK
Steinberg, G. R., & Hardie, D. G. (2023) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-022-00547-x · Cited by 1,006
Self-citationBian, X., Liu, R., Meng, Y., Xing, D., Xu, D., & Lu, Z. (2021) · Journal of Experimental Medicine · doi:10.1084/jem.20201606 · Cited by 983
Lipid metabolism in cancer: New perspectives and emerging mechanisms
Broadfield, L. A., Pane, A. A., Talebi, A., Swinnen, J. V., & Fendt, S.-M. (2021) · Developmental Cell · doi:10.1016/j.devcel.2021.04.013 · Cited by 758
Self-citationAMP-activated protein kinase: the current landscape for drug development
Steinberg, G. R., & Carling, D. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0019-2 · Cited by 754
Self-citation
Metadata
- Authors
- Lally, J. S. V., Ghoshal, S., DePeralta, D. K., Moaven, O., Wei, L., Masia, R., Erstad, D. J., Fujiwara, N., Leong, V., Houde, V. P., Anagnostopoulos, A. E., Wang, A., Broadfield, L. A., Ford, R. J., Foster, R. A., Bates, J., Sun, H., Wang, T., Liu, H., Ray, A. S., Saha, A. K., Greenwood, J., Bhat, S., Harriman, G., Miao, W., Rocnik, J. L., Westlin, W. F., Muti, P., Tsakiridis, T., Harwood, H. J., Kapeller, R., Hoshida, Y., Tanabe, K. K., Steinberg, G. R., & Fuchs, B. C.
- Venue
- Cell Metabolism
- Publisher
- Elsevier BV
- Published
- 2019-01
- Volume
- 29
- Issue
- 1
- Pages
- 174-182.e5
- ISSN
- 1550-4131 (ISSN-L)
- OpenAlex
- W2890605550
- Cited by
- 410
- References
- 36
- FWCI
- 8.20
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.